Halfol-XT Tablet is a combination pharmaceutical formulation containing Ferrous Ascorbate 100 mg and Folic Acid 1.5 mg, primarily indicated for the prevention and treatment of iron deficiency anemia and folate deficiency. Ferrous Ascorbate, a complex of iron and ascorbic acid (vitamin C), enhances iron absorption and replenishes iron stores essential for hemoglobin synthesis and red blood cell production. Folic Acid, a vital B-vitamin, plays a crucial role in DNA synthesis, cellular division, and erythropoiesis, thereby supporting effective hematopoiesis. Halfol-XT is particularly beneficial in conditions such as nutritional anemia, pregnancy, lactation, chronic blood loss, and other states associated with increased iron and folate requirements. The tablet is administered orally, with dosage tailored according to the severity of deficiency and patient-specific factors. Common adverse effects may include gastrointestinal disturbances such as nausea, constipation, or abdominal discomfort, which are generally mild and transient. Caution is advised in patients with hemochromatosis or hypersensitivity to any component. Regular monitoring of hematological parameters is recommended to assess therapeutic response and avoid iron overload. Halfol-XT Tablet offers an effective and well-tolerated approach to managing iron and folate deficiencies, contributing to improved patient outcomes in anemia management.